Germicidal UV-C System Kills Airborne Pathogens
By HospiMedica International staff writers Posted on 25 Nov 2020 |
Image: The PE 254 pathogen-eradication system (Photo courtesy of NoviSphere)
Rarified-environment technology uses ultraviolet (UV)-C light to kill 99.99% of airborne pathogens, creating ultraclean environments.
The NoviSphere (Elk Grove Village, IL, USA) PE 254 is a cost-effective, high-performance UV pathogen-eradication system that uses fully contained and sealed 254nm UV-C lamps and proprietary baffling technology to kill up to 99.99% of airborne viruses, bacteria, and mold spores. Extensive independent testing has confirmed it also eradicates 99.99% of an aerosol coronavirus strain (HuCov229E), a single-stranded RNA virus that is similar to the COVID-19 strain that causes respiratory illnesses in humans. Further testing is planned to verify 99.9999999% eradication (one part per billion).
The system removes all pathogens in the air, as well as other contaminants, via a variable speed control, that continuously provides up to four complete air changes per hour in a room of an average size. The compact system can be used in virtually any large public setting, including (but not limited to), hospitals, schools, warehouses, manufacturing plants, hospitality, mass transit centers, sports facilities, and a range of industrial and commercial settings.
“At NoviSphere, our mission is to deliver confidence and safety to customers in their communities, workplaces, and businesses. Rarified environments we enable through our technologies are pathogen and particulate free; essentially, a magnitude better than today’s stringent ultraclean standards,” said Paul Lockhart, CEO of NoviSphere. “As a former astronaut entrusted with some of our nation’s most critical assets, I can think of no endeavor more important than what we are embarking on at NoviSphere.”
“Published papers in Aerosol Science & Technology show it is particularly effective against single-stranded RNA viruses,” said Chris Hogan, PhD, of the department of mechanical engineering at the University of Minnesota (Minneapolis, USA), who conducted the testing. “Coronaviruses, and more specifically, SARS-CoV-2, are single-stranded RNA viruses and would be highly susceptible to UV-C activation. Sealed, ducted UV-C sources with flow rates above 10 CFM are an effective approach.”
UVC light in the 254 nm wavelength induces the formation of pyrimidine dimmers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, destroying the organisms or rendering them unable to reproduce. Intense UV-C light also has a proven track record of virus inactivation in aerosols.
Related Links:
NoviSphere
The NoviSphere (Elk Grove Village, IL, USA) PE 254 is a cost-effective, high-performance UV pathogen-eradication system that uses fully contained and sealed 254nm UV-C lamps and proprietary baffling technology to kill up to 99.99% of airborne viruses, bacteria, and mold spores. Extensive independent testing has confirmed it also eradicates 99.99% of an aerosol coronavirus strain (HuCov229E), a single-stranded RNA virus that is similar to the COVID-19 strain that causes respiratory illnesses in humans. Further testing is planned to verify 99.9999999% eradication (one part per billion).
The system removes all pathogens in the air, as well as other contaminants, via a variable speed control, that continuously provides up to four complete air changes per hour in a room of an average size. The compact system can be used in virtually any large public setting, including (but not limited to), hospitals, schools, warehouses, manufacturing plants, hospitality, mass transit centers, sports facilities, and a range of industrial and commercial settings.
“At NoviSphere, our mission is to deliver confidence and safety to customers in their communities, workplaces, and businesses. Rarified environments we enable through our technologies are pathogen and particulate free; essentially, a magnitude better than today’s stringent ultraclean standards,” said Paul Lockhart, CEO of NoviSphere. “As a former astronaut entrusted with some of our nation’s most critical assets, I can think of no endeavor more important than what we are embarking on at NoviSphere.”
“Published papers in Aerosol Science & Technology show it is particularly effective against single-stranded RNA viruses,” said Chris Hogan, PhD, of the department of mechanical engineering at the University of Minnesota (Minneapolis, USA), who conducted the testing. “Coronaviruses, and more specifically, SARS-CoV-2, are single-stranded RNA viruses and would be highly susceptible to UV-C activation. Sealed, ducted UV-C sources with flow rates above 10 CFM are an effective approach.”
UVC light in the 254 nm wavelength induces the formation of pyrimidine dimmers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, destroying the organisms or rendering them unable to reproduce. Intense UV-C light also has a proven track record of virus inactivation in aerosols.
Related Links:
NoviSphere
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration